Upgrade to SI Premium - Free Trial

Abbott (ABT) PT Jumps To $74 From $68 On Organic Revenue Growth Acceleration - Jefferies

July 19, 2018 6:46 AM
Jefferies analyst, Raj Denhoy, reiterated his Buy rating on shares of Abbott Labs (NYSE: ABT) and raised his price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles